Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GYRO > SEC Filings for GYRO > Form 8-K on 19-Feb-2009All Recent SEC Filings

Show all filings for GYRODYNE CO OF AMERICA INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for GYRODYNE CO OF AMERICA INC


19-Feb-2009

Entry into a Material Definitive Agreement, Financial Statements and E


Item 1.01. Entry into a Material Definitive Agreement.

On February 2, 2009, Gyrodyne Company of America, Inc. (the "Company") entered into a Purchase and Sale Agreement (the "Agreement") between the Company and Fairfax Medical Center, LLC (the "Seller") to acquire the land and buildings comprising a medical office complex known as the Fairfax Medical Center in Fairfax, Virginia, located at 10721 Main Street (the "Property"). The Property consists of approximately 59,000 square feet of rentable space and a current occupancy rate of 84%. The purchase price per square foot is approximately $223.05. Other than with respect to the Agreement itself, there is no material relationship between the Company and the Seller.

The purchase price for the Property is $13,160,000, $100,000 of which was paid as a refundable deposit upon the signing of the Agreement, and the remainder is required to be paid at closing. The closing is expected to take place on or about March 31, 2009 but in no event later than April 30, 2009, and is subject to customary representations and conditions, including the condition that the Company obtain financing in a principal amount equal to or greater than 59% of the purchase price, or $8 million, in the form of a new loan or, in the Company's discretion, assumption and modification of existing debt secured against the Property. The Agreement is subject to a 45-day inspection period during which the Company may, at its own expense, arrange for legal, environmental and/or engineering analyses. The Company may terminate the Agreement prior to the expiration of the inspection period in the event that the Seller fails to cure any title or survey objections pursuant to the terms of the Agreement.

Upon acquisition, the Company intends to continue to operate the office space pursuant to existing leases.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Press Release of Gyrodyne Company of America, dated February 19, 2009.


  Add GYRO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GYRO - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.